Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.01 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including brain inhibitory neurons; strongest in oocytes | 0.75 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 6 Parkinson's papers of 53 | 0.74 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 10653
Sealed predictions
- NPAS1 in dopamine neurons, braak-0.63 (p 0.068) → -0.03 (p 0.947)receipt 10660
Swarm cases
receipt 10660: NPAS1 in dopamine neurons, braak
- power
- full sample -0.34 (p 0.164, n 18), 95% CI -0.70 to +0.15. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.39 (p 0.109, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.46 (p 0.057, n 18). could be the mix.
- skeptic
- leave-one-out range -0.50 to -0.26, sign flips 0; without severely affected donors -0.34 (p 0.164, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NPAS1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts